TEST:

HEPA eDX

"Gencurix...begins clinical trials of HEPA eDX, a liquid biopsy liver cancer early diagnosis test. If successful in clinical trials, HEPA eDX is expected to become the world's first commercially successful liver cancer early diagnosis product...The company aims to complete clinical trials by the first quarter of next year and complete approval from the Ministry of Food and Drug Safety within the first half of next year. The strategy is to make every effort to prepare for the official release at the same time as the approval."